Thyroxine reverses deficits of nerve growth factor and epidermal growth factor in submandibular glands of mice with muscular dystrophy.
D000818:Animals; D004815:Epidermal Growth Factor / Q000378:metabolism*; D005260:Female; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D009137:Muscular Dystrophy, Animal / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D009414:Nerve Growth Factors / Q000172:deficiency*; D012737:Sex Factors; D013363:Submandibular Gland / Q000378:metabolism* / Q000648:ultrastructure; D013739:Testosterone / Q000627:therapeutic use; D013974:Thyroxine / Q000097:blood / Q000627:therapeutic use*; D014284:Triiodothyronine / Q000097:blood
D009414:Nerve Growth Factors; D014284:Triiodothyronine; D013739:Testosterone; D004815:Epidermal Growth Factor; D013974:Thyroxine